Educational Video Versus In-person Genetic Counseling for Hereditary Cancer
Randomized Non Inferiority Trial of Educational Video Versus In-person Genetic Counseling for Hereditary Cancer
1 other identifier
interventional
251
1 country
1
Brief Summary
The identification of mutations in cancer susceptibility genes is important as it makes it possible to recommend specific cancer treatments, implement risk reduction strategies or early detection of cancer, and identify family members at risk. The guidelines for evaluating patients who are candidates for genetic testing recommend pre-test genetic counseling. However, the limited number of specialists trained to provide genetic counseling worldwide, and particularly in developing countries such as Mexico, makes it difficult to implement such recommendations. The present proposal aims to compare, through a randomized non-inferiority study, a pre-test education strategy using a pre-recorded video against in-person counseling. This strategy could potentially increase access in places with limited resources. The general hypothesis of the research is that patients who are candidates for cancer genetic susceptibility testing who receive pre-test education via video will consent to genetic testing in the same proportion as those who receive it during an in-person visit. The specific objectives of the study include: 1) to compare the proportion of patients who are tested in both groups; 2) to assess knowledge about hereditary cancer in both groups after the intervention; 3) assess anxiety symptoms in both groups after the intervention; and 4) assess satisfaction with the information received during the intervention.Patients \>18 years of age who meet the criteria for genetic testing to evaluate genetic cancer susceptibility genes and who have not previously undergone genetic testing or genetic counseling will be invited. The intervention group will receive education via pre-recorded video and the control group will receive genetic counseling during an in-person consultation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 10, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
January 3, 2023
CompletedFirst Submitted
Initial submission to the registry
February 7, 2023
CompletedFirst Posted
Study publicly available on registry
April 10, 2023
CompletedApril 10, 2023
April 1, 2023
2.3 years
February 7, 2023
April 6, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Genetic testing acceptance
Proportion of patients that accept to undergo a genetic testing
up to 12 weeks
Secondary Outcomes (2)
Genetic cancer knowledge change (pre and post intervention)
up to 24 hours after intervention
Anxiety level (pre and post intervention)
up to 24 hours after intervention
Study Arms (2)
Educational Video
EXPERIMENTALThe patient will watch a 15-minute video on an electronic tablet that includes the following items: * What is hereditary cancer? * Inheritance risk * Who are candidates for a genetic test? * What is a genetic testing and how can it help? * What types of results can be expected from genetic testing? * Reactions to the result of the genetic test * Clinical care according to the results * Any common questions? When the patient finish watching the video, he/she would have the opportunity to resolve any doubts.
In-Person genetic counseling
ACTIVE COMPARATORPatients will receive pre-test genetic counseling in person with a specialist using the usual protocols existing at the Institute and systematically includes the following: Family history of cancer Personal cancer risk assessment Education on inheritance and disease expression Types of tests and results (positive, negative and variants of uncertain significance). Limitations of the genetic study Preparation of possible outcomes according to results Risks Additional information: confidentiality of the results, costs and test options. Opportunity will be given to resolve doubts
Interventions
Pre-recorded educational video including hereditary cancer information, genetic cancer testing candidates, types of testing, type of results, benefits and risks, recommendations according to results, inheritance and common questions.
Includes: Family history of cancer (3-generation family tree) Personal Cancer Risk Assessment Education on inheritance and expression of disease Types of tests Preparation on possible outcomes according to results Obtaining consent for test Opportunity to solve doubts
Eligibility Criteria
You may qualify if:
- Meet cancer genetic testing criteria
You may not qualify if:
- Had a genetic testing before
- Had genetic counseling before
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
Mexico City, Mexico
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 7, 2023
First Posted
April 10, 2023
Study Start
August 10, 2020
Primary Completion
November 30, 2022
Study Completion
January 3, 2023
Last Updated
April 10, 2023
Record last verified: 2023-04
Data Sharing
- IPD Sharing
- Will not share